Stanford Medcast Episode 42: Hot Topics Mini-Series - Gut Microbiome in Multiple Sclerosis

1. Determine how the the gut microbiome has an influence on the immune response in patients with MS.
2. Counsel patients about the importance of a heart healthy diet.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
1.Ochoa-Repáraz, J., Kirby, T. O., & Kasper, L. H. (2018). The Gut Microbiome and Multiple Sclerosis. Cold Spring Harbor perspectives in medicine, 8(6), a029017. https://doi.org/10.1101/cshperspect.a029017
2.Jangi, S., Gandhi, R., et al. Alterations of the human gut microbiome in multiple sclerosis (2016). Nat. Commun. 7:12015. doi: 10.1038/ncomms12015
3.Reynders, T., Devolder, L., Valles-Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., Nagels, G., D'hooghe, M., & Raes, J. (2020). Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Annals of clinical and translational neurology, 7(4), 406–419. https://doi.org/10.1002/acn3.51004
4.Al Bander, Z., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020). The Gut Microbiota and Inflammation: An Overview. International journal of environmental research and public health, 17(20), 7618. https://doi.org/10.3390/ijerph17207618

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity. 

Faculty Member Information

Role in activity

Name of Ineligible Company(s) / Nature of Relationship(s)

Ruth Adewuya, MD, CHCP
Managing Director, CME
Stanford University School of Medicine

Course Director

Nothing to disclose

Emmanuelle Waubant, MD
UCSF

Faculty

Nothing to disclose

Ishita Verma
Student
Stanford University

Planner

Nothing to disclose

This CME Activity is supported in by an educational grant from Novartis Pharmaceuticals Corporation.